Erin Gillespie, MD, MPH
Jonathan Yang, MD, PhD,
Open to Accrual
Symptom Management [CC]
Bone Mets
III
No
To determine whether prophylactic radiationtherapy (RT) to high-risk asymptomatic bone metastases decreases the occurrenceof skeletal-related events (SREs), including pathologic fracture, spinal cordcompression, and surgery to bone (not including palliative radiation for painonly), compared to standard of care (SOC).
Patients with polymetastatic cancer defined as more than 5 sites of radiographically-evident systemic metastatic disease (excluding intracranial disease).
280
We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More
NRG Oncology Foundation, Inc, is a nonprofit, tax-exempt foundation. Donations to NRG Oncology help us conduct this important mission, and are tax-deductible to the extent permitted by law.